Phase 4
N=20
Randomized Trial of Ropivacaine & Bupivacaine for Inflatable Penile Prosthesis
Erectile Dysfunction
Bottom Line
View on ClinicalTrials.gov: NCT04801368 ↗Enrolled (actual)
20
Serious AEs
0.0%
Results posted
Feb 2025
Primary outcome: Primary: Visual-analogue Pain Scale — 6; 4 units on a scale
Study Design & Population
- Study type
- Interventional
- Phase
- Phase 4
- Interventions
- Randomization of two local anesthetics. (Drug)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- Male
- Sponsor
- Mayo Clinic
- Primary completion
- Jan 2024
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Visual-analogue Pain Scale |
2.8; 3.56 | — |
| PRIMARY Visual-analogue Pain Scale |
2.8; 3.56 | — |
| PRIMARY Visual-analogue Pain Scale |
2.8; 3.56 | — |
| PRIMARY Visual-analogue Anxiety Scale |
2; 2.44 | — |
| PRIMARY Visual-analogue Anxiety Scale |
2; 2.44 | — |
| PRIMARY Visual-analogue Anxiety Scale |
2; 2.44 | — |
Summary
The purpose of this research is to determine the effects of penile ring block for local anesthesia with liposomal bupivacaine vs ropivacaine mixture in subjects undergoing surgery for Penile Prosthesis Placement.
Eligibility Criteria
Inclusion Criteria
- Men undergoing 3-piece penile prosthesis placement under general anesthesia at Mayo Clinic - Rochester.
- ≥ 18 years old.
Exclusion Criteria
- History of opioid exposure within the preceding 90 days prior to surgery (based on patient-report, review of the electronic medical record, and NMP prescribing database review)
- Current or prior history of alcohol or drug abuse (illicit or prescription)
- History of chronic pain conditions (chronic musculoskeletal pain, fibromyalgia, central sensitization, chronic pelvic pain syndrome, etc.)
- History of cardiac arrhythmia or untreated severe cardiovascular disease
- Uncontrolled hypertension
- Hepatic insufficiency
- Renal insufficiency (CKD stage IIIa or greater)
- Current anti-platelet or anti-coagulation therapy with plans to continue at the time of prosthesis placement
- Poorly controlled diabetes mellitus (defined as HgbA1c > 8.5 within 30 days of surgery)
- Concurrent adjunctive operative procedures planned at the time of penile prosthesis placement (examples: male urethral sling, Peyronie's disease straightening with penile plication or incision/grafting)
- Concurrent non-prosthetic surgery planned at the time of penile prosthesis placement (examples: circumcision, hernia repair, hydrocelectomy, etc.)
- Planned infrapubic or subcoronal incision at the time of penile prosthesis placement
- Patients who will be undergoing prosthesis placement using local, monitored, or spinal anesthesia (i.e. non-general anesthesia)
- Allergy or history of intolerance to any local anesthetic agents included in the protocol
- History of prior penile prosthesis or artificial urinary sphincter surgery
- Revision penile prosthesis surgery
Data sourced from ClinicalTrials.gov (NCT04801368). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.